Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 4/20 | 0.47 |
| ▸ | TSPO | P30536 | 1/20 | 0.47 |
| ▸ | PTGER4 | P35408 | 9/20 | 0.43 |
| ▸ | RAC2 | P15153 | 1/20 | 0.43 |
| ▸ | RAC3 | P60763 | 1/20 | 0.43 |
| ▸ | CDC42 | P60953 | 1/20 | 0.43 |
| ▸ | RAC1 | P63000 | 1/20 | 0.43 |
| ▸ | PTGES | O14684 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | HBB | P68871 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23790653 | 0.96 | NPY5R (0.48) | NPY5RTSPOPTGER4RAC2RAC3 | |
| SCHEMBL23790652 | 0.89 | NPY5R (0.46) | NPY5RTSPOPTGER4RAC2RAC3 | |
| SCHEMBL25491307 | 0.83 | TSPO (0.50) | NPY5RTSPOPTGER4RAC2RAC3 | |
| SCHEMBL16865778 | 0.82 | NPY5R (0.58) | NPY5RTSPOPTGER4RAC2RAC3 | |
| SCHEMBL12034124 | 0.80 | NPY5R (0.56) | NPY5RTSPOPTGER4RAC2RAC3 | |
| SCHEMBL12034062 | 0.80 | NPY5R (0.56) | NPY5RTSPOPTGER4RAC2RAC3 | |
| SCHEMBL23790854 | 0.80 | TSPO (0.37) | NPY5RTSPOPTGER4MEN1ALDH1A1 | |
| SCHEMBL23790651 | 0.79 | L3MBTL1 (0.41) | TSPOPTGER4KDM4EMEN1ALDH1A1 | |
| SCHEMBL23790668 | 0.79 | KDM4E (0.43) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL24667559 | 0.77 | KDM4E (0.63) | NPY5RTSPOPTGER4RAC2RAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11818953-B2 | Heterocyclic compound, organic light-emitting device including heterocyclic compound, and electronic apparatus including organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-14 | — | — | US | disclosed |
| US-11818953-B2 | Heterocyclic compound, organic light-emitting device including heterocyclic compound, and electronic apparatus including organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-14 | — | — | US | disclosed |
| US-20210280798-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11818953-B2 | Heterocyclic compound, organic light-emitting device including heterocyclic compound, and electronic apparatus including organic light-emitting device | CYP2E1, CRY1, CYP1A1 | NPY5R 3438/4885TSPO 1407/4885PTGER4 996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.